|
Nengneng Cheng, Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Drug Safety | Pharmacovigilance | Adverse Drug Reactions | Pharmacokinetics | Pharmacodynamics | Quantitative Analysis | Clinical Pharmacology | Toxicology | Therapeutic Drug Monitoring | Regulatory Science |
|
Wei Guo, Associate Professor
Fudan University, Pharmaceutical Sciences
Area of Focus
Ischemic Heart Failure | Early Intervention | Cellular Mechanisms | Molecular Mechanisms | Drug Targets | Drug Screening | Hydrogen Sulfide | Signal Transduction | Acute Myocardial Infarction | Cardiovascular Research |
|
Hong Zhu, Professor, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Yap | Taz | Oncogenic Transcription Factors | Regulation Mechanisms | Intervention Strategies | Anti-Tumor Drug Targets | Candidate Drugs | Transcription Factor Regulation | Cancer Research | Pharmacology |
|
Xiangnan Zhang, Professor, Doctoral Supervisor, Vice Dean of the School of Pharmacy
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Stroke | Neuroprotection | Mechanisms | Neuropharmacology | Mitochondrial | Autophagy | Neuropsychiatric | Diseases | Drug Targets | Ischemia |
|
Meidan Ying, Professor, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Tumor | Pharmacology | Cancer | Drug Targets | Pediatric | Malignant | Innovative Drugs | Research | Mechanisms | Regulation |
|
Qinjie Weng, Professor, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Immunopharmacology | Autoimmune Diseases | Immune Mechanisms | Intervention Strategies | Natural Immune Regulation | Key Proteins | Potential Treatments | Drug Safety | Toxicology | Innovative Drugs |
|
Wei Xie, Researcher, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Nucleic Acid Recognition | Anti-Infection | Anti-Tumor | Pharmacology | Immune Response | Drug Targets | Molecular Intervention | Mechanism Of Action | Drug Discovery | Molecular Mechanisms |
|
Hui Li, Distinguished Researcher, Doctoral Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Liver Toxicology: Liver | Toxicity | Hepatotoxicity | Drug Metabolism | Clinical Significance | Regulation | Non-Genetic Factors | Intervention Strategies | Drug-Induced Liver Injury | Toxicology | Reproductive Toxicology: Reproductive | Male Reproductive Toxicity | Testis | Epididymis | Sperm | Drug Exposure | Environmental Compounds | Alternative Toxicology: Alternative Methods | Non-Animal Testing | In Vitro | In Silico | Risk Assessment | Regulatory Science | Safety Evaluation | Toxicological Research | Clinical Relevance |
|
Danyan Zhu, Associate Professor, Master's Supervisor
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Cardiovascular Pharmacology: Heart | Blood Vessels | Drugs | Pharmacodynamics | Pharmacokinetics | Cardiovascular Diseases | Therapeutic Agents | Toxicology | Clinical Trials | Molecular Mechanisms | Stem Cell Biology: Stem Cells | Differentiation | Regeneration | Cell Therapy | Embryonic Stem Cells | Adult Stem Cells | Pluripotency | Cell Signaling | Tissue Engineering | Gene Expression | Drug Toxicology: Toxicology | Drug Safety | Adverse Effects | Pharmacovigilance | Toxicokinetics | Risk Assessment | Biomarkers | In Vitro Models | In Vivo Models | Regulatory Toxicology |
|
Xuejing Shao, Distinguished Researcher
Zhejiang University , Pharmaceutical Sciences
Area of Focus
Cancer | Pharmacology | Leukemia | Fusion Proteins | Drug Targets | Tumor Cell Differentiation | Innovative Drugs | Therapeutic Strategies | Post-Translational Modifications | Small Molecule Drugs |
